^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | B Acute Lymphoblastic Leukemia |
| Drug: | vincristine (Tubulin polymerization inhibitor) + prednisone (Steroid receptor agonist) + daunorubicin (Topoisomerase II inhibitor, DNA intercalator) + Oncaspar liquid (pegaspargase) (Asparagine depleter, Aspartate-ammonia ligase inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Published date:
04/04/2022
Excerpt:
Acute Lymphoblastic Leukemia...Preferred Regimens...CALGB 10403 regimen: daunorubicin, vincristine, prednisone, and pegaspargase
